(Q51593209)

7 April 2018

title

Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab. (English)

1 reference

7 April 2018

interstitial lung disease

main subject

1 reference

Wan-Hee Yoo

1

1 reference

7 April 2018

publication date

8 January 2010

1 reference

7 April 2018

Rheumatology International

published in

1 reference

7 April 2018

volume

32

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

795-798

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/s00296-009-1347-z

exact match

0 references

cites work

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

B lymphocytes and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

Systemic and cell type-specific gene expression patterns in scleroderma skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1347-Z

B cell infiltration in systemic sclerosis-associated interstitial lung disease

21 January 2018

1 reference

12 December 2020

Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.

1 reference

12 December 2020

Progressive systemic sclerosis - long-term treatment with azathioprin (author's transl)

1 reference

12 December 2020

Mycophenolate mofetil for interstitial lung disease in scleroderma

1 reference

12 December 2020

Pulmonary involvement in systemic sclerosis (scleroderma)

1 reference

12 December 2020

10.1007/S00296-009-1347-Z

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018